Is President Trump going to impact patient safety?

by | Clinical Trials

This come across my desk, and I wanted to make sure you saw it.

Quick Synopsis in case you don’t want to read the article: President Trump has announced that he isn’t a fan of excessive government oversight. He believes that there are too many regulations and this is part of the reasons that drug development has slowed down. He has hence proposed that for every new regulation that is put in, 2 regulations should be removed. However, there are concerns that this may impact patient safety in clinical trials. The order has already been challenged in court as being arbitrary and capricious.

Send me a message if you have any questions:

5 + 3 =